TickerFacts.

Company research / PRCT

PROCEPT BioRobotics Corp (PRCT)

Build a valuation ↗↓ Download CSV

CIK 0001588978 · Nasdaq · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, PROCEPT BioRobotics Corp reported revenue of $308.05M. Revenue grew 37.2% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $337.34M.

Key ratios (year ended 2025-12-31)

63.7%
Gross margin
-33.7%
Operating margin
-31.0%
Net margin
-26.1%
Return on year-end equity
37.2%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-05

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-31
Revenue$337.34M$308.05M$224.50M$136.19M$75.01M$34.47M$7.72M
Cost of Revenue$120.69M$111.83M$87.40M$65.14M$37.93M$18.61M$8.97M
Gross Profit$216.65M$196.23M$137.10M$71.05M$37.09M$15.87M-$1.25M
R&D Expense$78.81M$71.28M$62.30M$48.45M$28.98M$18.99M$16.27M
Operating Income-$114.23M-$103.86M-$96.61M-$109.17M-$80.72M-$54.16M-$47.80M
Depreciation & Amortization$7.05M$6.39M$5.23M$3.81M$2.84M$3.32M$2.86M
EBITDA-$107.18M-$97.47M-$91.38M-$105.36M-$77.88M-$50.84M-$44.94M
Net Income-$109.75M-$95.57M-$91.41M-$105.90M-$87.15M-$59.85M-$53.02M
EPS (Diluted)n/a-$1.72-$1.75-$2.24-$1.96-$3.63-$14.47
Total Assets$479.35M$508.08M$534.02M$404.72M$309.33M$337.02M$125.97M
Total Liabilities$139.28M$142.21M$131.80M$123.97M$112.26M$69.93M$65.01M
Long-Term Debt$51.72M$51.62M$51.47M$51.34M$51.21M$50.00Mn/a
Shareholders' Equity$340.07M$365.87M$402.22M$280.75M$197.07M$267.09M-$182.89M
Cash & Equivalents$227.91M$286.50M$333.73M$257.22M$221.86M$304.32M$100.13M
Operating Cash Flow-$74.34M-$48.98M-$99.21M-$108.00M-$80.38M-$57.33M-$48.34M
Capital Expenditures$10.59M$9.36M$4.41M$25.21M$2.65M$592.0K$233.0K
Free Cash Flow-$84.92M-$58.34M-$103.62M-$133.21M-$83.03M-$57.93M-$48.58M
Shares Outstanding57.25M56.32M54.72M50.77Mn/a43.68M4.71M
Weighted Average Diluted Sharesn/a55.54M52.12M47.26M44.40M16.48M3.66M
EPS (Basic)n/a-$1.72-$1.75-$2.24-$1.96-$3.63-$14.47

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView